characteristics.2 Six of these characteristics form the key to diagnosis: (1) dystopia canthorum, (2) a broad nasal root, (3) hypertrichosis of the medial ends of the eyebrows, (4) hypopigmentation of the skin and head hair, (5) total or partial heterochromia iridis, and (6) congenital unilateral or bilateral deafness.6 Some of the phenotypic effects caused by WS1 are illustrated by a 23 year old female who has significant hearing loss and her 5 year old daughter who is profoundly deaf (fig la, b) .
Premature graying of head hair and beard occurs in approximately 33% of subjects with WS1,7 while optic abnormalities including iridial hypoplasia, hypopigmentation of the fundus, coloboma, and microphthalmia occur in approximately 51% of the cases reported.' 7 8-12 WS1 subjects may also exhibit cleft lip, cleft palate, or cleft face with a frequency of up to 10%,7 13 4while cardiac abnormalities including septal defects are occasionally observed.2 3 [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] In families where radiographical studies have been performed, high frequencies of minor skeletal abnormalities are observed. ' 1921 In certain extended families, dystopia canthorum shows a penetrance of 98% and serves as a reliable indicator of Waardenburg syndrome.' In these families, penetrance of bilateral profound deafness in heterozygotes was initially reported as 17%,' but with a larger data set this frequency is closer to 25%. 22 The frequency of Waardenburg syndrome among students from schools for the deaf in the Netherlands and Canada is 1-43% and 2-7%, respectively, with an estimate of affected persons in the general population of 1/42 000 and a mutation rate of 1/270 000.1 23 The WS1 mutation is a significant cause of congenital deafness and hearing impairment in humans.
Observing the range of phenotypes initially reported by Waardenburg,l investigators have defined four different subdivisions of Waardenburg syndromes.
Arias,6 24 and later Hageman and Delleman, 22 suggested that patients with Waardenburg syndrome but lacking dystopia canthorum should be classified A genetic and developmental analysis of Waardenburg syndromes will determine: (1) the number of genetic loci responsible for Waardenburg syndromes, (2) the number of mutant alleles at a given locus with different phenotypic effects, (3) the primary functions of the loci involved, and (4) the mechanisms by which alterations of these primary functions produce abnormalities of the eye, inner ear, pigmentation, and skeleton. An obvious first step to obtain this information is to assign WS 1 and WS2 to particular human chromosomes using RFLP markers with known map positions. To narrow the initial choice of autosomal RFLP markers to be used in such a linkage analysis, mutations in other mammals which may be homologous to WS 1 and WS2 can be used to predict possible chromosomal locations of Waardenburg syndromes. 104 Phenotypic similarities between mutations at the mi locus and mutations causing Waardenburg syndromes suggest a fourth possible chromosomal position for the location of Waardenburg syndromes. The mi locus is located on mouse chromosome 6 to which 47 other loci have been mapped.69' 80 The syntenic relationships among homologous genes found on mouse chromosomes 6 and 9 and three human chromosomes, 3, 7, and 12, are illustrated in fig 2A and relationships between genes on mouse chromosome 6 and human chromosomes 3, 7, and 12.80 81 closest marker to mi is Raf-l a proto-oncogene, reported to be 1 map unit from mi (fig 2A) . 10 The human homologue RAFI has been cloned and mapped to human chromosome 3. 107 The observations supporting the possibility that WS 1 may be on the short arm of human chromosome 3 are: (1) the possible homology between Mio' and WS1, (2) the close linkage between mi and Raf-1, (3) the average length of conserved chromosome segments of 10-1±2-2 cM of mouse genes whose homologues are found in humans, and (4) the fact that there are at least three established syntenic relationships between mouse chromosome 6 and human chromosome 3 involving RAFI,t07 108 RHO (rhodopsin),'06 109 and RPN1 (ribophorin 1).1t0 Given the syntenic relationships between mouse chromosomes 6 and 9 and human chromosome 3 (fig 2A and B 
